ID Name Structure References (top 5) Molecular Target(s)
1ID:7813
ZIGU-GLYCOSIDE II

Freqency:
in 1 ingredients:

  • 109
  • in 10 recipes:

  • 6
  • 39
  • 77
  • 210
  • 269
  • 300
  • 337
  • 508
  • 510
  • 514

  • Properties
    C35H56O8    604.82





    1:  Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J.
    Comparison of caspofungin and amphotericin B for invasive candidiasis.
    N Engl J Med.    impact factor:   28.857
    2002;  347(25): 2020-9

    2:  Fischbach W, Goebeler-Kolve M, Starostik P, Greiner A, Muller-Hermelink HK.
    Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori.
    Lancet.    impact factor:   10.197
    2002;  360(9332): 547-8

    3:  Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC.
    Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.
    Circulation.    impact factor:   9.903
    2002;  106(22): 2781-6

    4:  Toutant M, Costa A, Studler JM, Kadare G, Carnaud M, Girault JA.
    Alternative splicing controls the mechanisms of FAK autophosphorylation.
    Mol Cell Biol.    impact factor:   9.866
    2002;  22(22): 7731-43

    5:  Cebrian A, Garcia-Ocana A, Takane KK, Sipula D, Stewart AF, Vasavada RC.
    Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro.
    Diabetes.    impact factor:   9.019
    2002;  51(10): 3003-13

     
    Time used: 109 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005